Related Experiment Video

Updated: Nov 2, 2025

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG
08:46

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG

Published on: March 7, 2017

17.2K

ITPRIP promotes glioma progression by linking MYL9 to DAPK1 inhibition

Changchun Cao1, Kang He2, Shaoxun Li2

  • 1Department of Pharmacy, The Affiliated Huaian NO.1 People's Hospital of Nanjing Medical University, 1 Huanghe West Road, Huaian 223300, China.

Cellular Signalling
|June 10, 2021
PubMed

Insights

In malignant gliomas, the tumor suppressor DAPK1 is silenced by ITPRIP. This interaction promotes tumor growth by inhibiting DAPK1 activity, offering a potential therapeutic target for glioma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Epigenetic silencing of the tumor suppressor DAPK1 contributes to malignant glioma progression.
  • The precise mechanisms driving DAPK1 repression in gliomas are not fully understood.

Purpose of the Study:

  • To elucidate the mechanism of DAPK1 repression in malignant gliomas.
  • To investigate the role of the DAPK1-ITPRIP-MYL9 complex in glioma tumorigenesis.

Main Methods:

  • Lentivirus co-infection and coimmunoprecipitation were used to identify and characterize protein interactions.
  • In vitro and in vivo experiments assessed the impact of ITPRIP-DAPK1 interaction on glioma growth.
  • Knockdown studies evaluated the role of ITPRIP, DAPK1, and MYL9 in complex formation and function.

Main Results:

  • A novel DAPK1-ITPRIP-MYL9 complex was identified in malignant glioma cells.
  • ITPRIP binds to the DAPK1 death domain, inhibiting its tumor-suppressive function.
  • Disrupting the ITPRIP-DAPK1 interaction or interfering with ITPRIP function suppressed glioma growth in vitro and in vivo.

Conclusions:

  • ITPRIP plays a critical role in DAPK1 inhibition within malignant gliomas.
  • The DAPK1-ITPRIP-MYL9 complex promotes glioma progression by impeding DAPK1 activity.
  • Targeting the ITPRIP-DAPK1 interaction presents a potential therapeutic strategy for malignant gliomas.
Keywords:
DAPK1GliomaITPRIPInteractionMYL9Phosphorylation

More Related Videos

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells12:52

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

16.1K
Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma09:17

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma

Published on: September 13, 2022

2.5K

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.7K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.8K